Evidence map›Paper›PMID 34238936›Full record

ArticleNature communications2021

Publisher Correction: Integrating genomics and metabolomics for scalable non-ribosomal peptide discovery.

Bahar Behsaz, Edna Bode, Alexey Gurevich, Yan-Ni Shi, Florian Grundmann, Deepa Acharya, Andrés Mauricio Caraballo-Rodríguez, Amina Bouslimani, Morgan Panitchpakdi, Annabell Linck and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Bahar Behsaz *Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA.
Edna Bode *Molecular Biotechnology, Department of Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Alexey GurevichCenter for Algorithmic Biotechnology, Institute of Translational Biomedicine, St. Petersburg State University, St Petersburg, Russia.
Yan-Ni ShiMolecular Biotechnology, Department of Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Florian GrundmannMolecular Biotechnology, Department of Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Deepa AcharyaTiny Earth Chemistry Hub, University of Wisconsin-Madison, Madison, WI, USA.
Andrés Mauricio Caraballo-RodríguezCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-5499-2728
Amina BouslimaniCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
Morgan PanitchpakdiCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
Annabell LinckMolecular Biotechnology, Department of Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Changhui GuanThe Jackson Laboratory of Medical Genomics, Farmington, CT, USA.
Julia OhThe Jackson Laboratory of Medical Genomics, Farmington, CT, USA.
Pieter C DorresteinCenter for Microbiome Innovation, University of California at San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-3003-1030
Helge B BodeMolecular Biotechnology, Department of Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany. helge.bode@mpi-marburg.mpg.de.ORCID http://orcid.org/0000-0001-6048-5909
Pavel A PevznerDepartment of Computer Science and Engineering, University of California San Diego, La Jolla, CA, USA. ppevzner@ucsd.edu.ORCID http://orcid.org/0000-0002-0418-165X
Hosein MohimaniComputational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, USA. hoseinm@andrew.cmu.edu.ORCID http://orcid.org/0000-0003-3980-2505

Funding

Metagenomes to Therapeutics: Defining the Rules for Engineering the Skin MicrobiomeDP2GM126893 · NIGMS · JACKSON LABORATORY · PI OH, JULIA · 2017 to 2017
$2.8M
NIGMS NIH HHS DP2 GM126893
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34238936
PMCPMC8266848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.